These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2562650)

  • 21. Assessment of risks in connection with use of a recombinant E. coli strain for production of human growth hormone.
    Dalbøge H; Madsen B; Jørgensen KD; Carlsen S
    Dan Med Bull; 1988 Feb; 35(1):84-91. PubMed ID: 3277799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.
    Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P
    Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption of bioactive human growth hormone after oral administration in the common carp (Cyprinus carpio) and its enhancement by deoxycholate.
    Hertz Y; Tchelet A; Madar Z; Gertler A
    J Comp Physiol B; 1991; 161(2):159-63. PubMed ID: 1869695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects.
    Ho KY; Weissberger AJ; Stuart MC; Day RO; Lazarus L
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):335-45. PubMed ID: 2598470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits.
    Colthorpe P; Farr SJ; Smith IJ; Wyatt D; Taylor G
    Pharm Res; 1995 Mar; 12(3):356-9. PubMed ID: 7617520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal delivery of human growth hormone through RF-microchannels.
    Levin G; Gershonowitz A; Sacks H; Stern M; Sherman A; Rudaev S; Zivin I; Phillip M
    Pharm Res; 2005 Apr; 22(4):550-5. PubMed ID: 15846462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung to blood passage of human growth hormone after intratracheal instillation: stimulation of growth in hypophysectomized rats.
    Folkesson HG; Hedin L; Weström BR
    J Endocrinol; 1992 Aug; 134(2):197-203. PubMed ID: 1402529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal absorption enhancers for biosynthetic human growth hormone in rats.
    O'Hagan DT; Critchley H; Farraj NF; Fisher AN; Johansen BR; Davis SS; Illum L
    Pharm Res; 1990 Jul; 7(7):772-6. PubMed ID: 2395807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone-like material in normal human tissues.
    Kyle CV; Evans MC; Odell WD
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1138-44. PubMed ID: 7028770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-alpha-phosphatidylcholine and alpha-cyclodextrin in rabbits.
    Agerholm C; Bastholm L; Johansen PB; Nielsen MH; Elling F
    J Pharm Sci; 1994 Dec; 83(12):1706-11. PubMed ID: 7891298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, production and pharmacodynamics of human growth hormone.
    Jørgensen JT; Chirstensen T; Jørgensen M; Jakobsen G
    Indian J Pediatr; 1991; 58 Suppl 1():23-32. PubMed ID: 1824371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
    Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
    Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational stabilization of human growth hormone.
    Filikov AV; Hayes RJ; Luo P; Stark DM; Chan C; Kundu A; Dahiyat BI
    Protein Sci; 2002 Jun; 11(6):1452-61. PubMed ID: 12021444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of radiolabeled human growth hormone into higher molecular weight moieties in human plasma in vivo and in vitro.
    Beitins IZ; Rattazzi MC; MacGillivray MH
    Endocrinology; 1977 Aug; 101(2):350-9. PubMed ID: 885106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of biosynthetic and pituitary human growth hormones in rats.
    Jørgensen KD; Monrad JD; Brøndum L; Dinesen B
    Pharmacol Toxicol; 1988 Aug; 63(2):129-34. PubMed ID: 3186618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of monomeric human growth hormone and big growth hormone into different molecular weight forms in vitro and after injection into humans.
    Bieler EU; Pitout MJ; Stroud SW; van Rooyen RJ
    Horm Res; 1977; 8(1):29-36. PubMed ID: 892705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection.
    Charman SA; Segrave AM; Edwards GA; Porter CJ
    J Pharm Sci; 2000 Feb; 89(2):168-77. PubMed ID: 10688746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic analysis of lactosaminated human growth hormone and human growth hormone].
    Li Y; Guan C; Zhang H; Chen Z; Li T; Pang Q
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):7-10. PubMed ID: 12501599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.